0001157523-22-000028.txt : 20220105 0001157523-22-000028.hdr.sgml : 20220105 20220105080956 ACCESSION NUMBER: 0001157523-22-000028 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220105 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ORGANIGRAM HOLDINGS INC. CENTRAL INDEX KEY: 0001620737 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38885 FILM NUMBER: 22509473 BUSINESS ADDRESS: STREET 1: 35A ENGLISH DR. CITY: MONCTON STATE: A3 ZIP: E1E 3X3 BUSINESS PHONE: 506-384-1571 MAIL ADDRESS: STREET 1: 35A ENGLISH DR. CITY: MONCTON STATE: A3 ZIP: E1E 3X3 FORMER COMPANY: FORMER CONFORMED NAME: ORGANIGRAM HOLDINGS INC DATE OF NAME CHANGE: 20140926 6-K 1 a52557947.htm ORGANIGRAM HOLDINGS INC. FORM 6-K

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of January 2022
 
Commission File No. 001-38885
 
ORGANIGRAM HOLDINGS INC.
(Translation of registrant's name into English)

35 English Drive
Moncton, New Brunswick, Canada E1E 3X3
(Address of principal executive office)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40‑F
 
Form 20-F  [  ]  Form 40-F  [X]
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)  [  ]
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)  [  ]
 

 
 
SUBMITTED HEREWITH
 

Exhibits
  

 


 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
ORGANIGRAM HOLDINGS INC.
 


/s/ Derrick West
______________________________________
Derrick West
Chief Financial Officer
 
Date:  January 5, 2022
 EX-99.1 2 a52557947ex99_1.htm EXHIBIT 99.1
 
 Exhibit 99.1


Organigram to Report First Quarter Fiscal 2022 Results on January 11, 2022

MONCTON, New Brunswick--(BUSINESS WIRE)--January 5, 2022--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2022 ended November 30, 2021 on Tuesday, January 11, 2022 before market open.

The Company will host a conference call to discuss its results with details as follows:

Date: January 11, 2022
Time: 8:00 am Eastern Time

To register for the conference call, please use this link: http://www.directeventreg.com/registration/event/7385048

To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call.

To access the webcast: https://event.on24.com/wcc/r/3574376/4E62A1D28ADF780D54B2E4FE4F5760FD

A replay of the webcast will be available within 24 hours after the conclusion of the call at https://www.organigram.ca/investors and will be archived for a period of 90 days following the call.

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly-owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused soft chews and candy in Canada.

Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult-use recreational cannabis brands, including The Edison Cannabis Company, Indi, Bag o’ Buds, SHRED and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

This news release contains forward-looking information. Forward-looking information, in general, can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “could”, “would”, “might”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “continue”, “budget”, “schedule” or “forecast” or similar expressions suggesting future outcomes or events. They include, but are not limited to, statements with respect to expectations, projections or other characterizations of future events or circumstances, and the Company’s objectives, goals, strategies, beliefs, intentions, plans, estimates, forecasts, projections and outlook, including statements relating to = timing for announcement of results. These statements are not historical facts but instead represent management beliefs regarding future events, many of which, by their nature are inherently uncertain and beyond management control. Forward-looking information has been based on the Company’s current expectations about future events.

Contacts

For Investor Relations enquiries:
investors@organigram.ca

For Media enquiries:
Megan McCrae
Senior Vice-President, Marketing and
Communications
megan.mccrae@organigram.ca